Cell line · CVCL_2765
Papers45
1 more article gives this line's RRID in its Methods without naming the line nearby, so it is not listed.
1 to 20 of 45
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Metabolic buffering restricts phenotype switching in melanoma. | EMBO J | 2026 | Its Methods give the RRID and name the line | PubMed | |
| RIPK4 function interferes with melanoma cell adhesion and metastasis. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| The lipid-metabolic enzyme HSD17B12 drives lysosomal degradation of PD-L1 potentiating anti-tumor immunity in a mouse model. | PLoS Biol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Tissue-dependent mechanosensing by cells derived from human tumors. | NPJ Biol Phys Mech | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Generation and functional analysis of melanoma antigen-specific CD8+ T cells derived from S/MAR vector-transfected human induced pluripotent stem cells. | Int J Cancer | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Pathway metabolite ratios reveal distinctive glutamine metabolism in a subset of proliferating cells. | Mol Syst Biol | 2025 | Its Methods give the RRID and name the line | PubMed | |
| The mechanosensitive channel ELKIN1 regulates cellular adaptations to simulated microgravity. | NPJ Microgravity | 2025 | Its Methods give the RRID and name the line | PubMed | |
| GLI2 Facilitates Tumor Immune Evasion and Immunotherapeutic Resistance by Coordinating WNT and Prostaglandin Signaling. | Cancer Res | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Pan-inhibition of super-enhancer-driven oncogenic transcription by next-generation synthetic ecteinascidins yields potent anti-cancer activity. | Nat Commun | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Tubulin-Targeted Therapy in Melanoma Increases the Cell Migration Potential by Activation of the Actomyosin Cytoskeleton─An In Vitro Study. | ACS Biomater Sci Eng | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Sex-dependent effects in the aged melanoma tumor microenvironment influence invasion and resistance to targeted therapy. | Cell | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Significant and Various Effects of ML329-Induced MITF Suppression in the Melanoma Cell Line. | Cancers (Basel) | 2024 | Its Methods give the RRID and name the line | PubMed | |
| PTEN Lipid Phosphatase Activity Suppresses Melanoma Formation by Opposing an AKT/mTOR/FRA1 Signaling Axis. | Cancer Res | 2024 | Its Methods give the RRID and name the line | PubMed | |
| IK Channel-Independent Effects of Clotrimazole and Senicapoc on Cancer Cells Viability and Migration. | Int J Mol Sci | 2023 | Its Methods give the RRID and name the line | PubMed | |
| 3D Spheroid Configurations Are Possible Indictors for Evaluating the Pathophysiology of Melanoma Cell Lines. | Cells | 2023 | Its Methods give the RRID and name the line | PubMed | |
| AP-1 transcription factor network explains diverse patterns of cellular plasticity in melanoma cells. | Cell Rep | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Data driven and biophysical insights into the regulation of trafficking vesicles by extracellular matrix stiffness. | iScience | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Oxidative stress from DGAT1 oncoprotein inhibition in melanoma suppresses tumor growth when ROS defenses are also breached. | Cell Rep | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Deciphering the Functional Role of RIPK4 in Melanoma. | Int J Mol Sci | 2021 | Its Methods give the RRID and name the line | PubMed | |
| Quantitative Proteomics of the Cancer Cell Line Encyclopedia. | Cell | 2020 | Cellosaurus cites it | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_2765/papers